Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
AGI Dermatics founded by Dr. Yarosh in 1985, has emerged as a world leader in DNA repair technology for skin and is best known for developing DimericineÒ, a drug that is under clinical testing for treating patients with skin cancers and pre-cancers. AGI Dermatics is also the developer of Remergent, a doctor-dispensed skincare line based on the science of DNA repair. ( www.agiderm.com )
AGI Dermatics
205 Buffalo Avenue
Freeport, New York 11520
USA
Tel: (516) 868-9026
Fax: (516) 868-9143